KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $141.98 $159.34 Thursday, 25th Apr 2024 ALNY stock ended at $143.71. This is 0.0626% less than the trading day before Wednesday, 24th Apr 2024. During the day the stock fluctuated 2.67% from a day low at $141.98 to a day high of $145.77.
90 days $141.98 $184.29
52 weeks $141.98 $218.88

Historical Alnylam Pharmaceuticals prices

Date Open High Low Close Volume
Jun 08, 2021 $152.00 $153.25 $149.98 $151.08 470 538
Jun 07, 2021 $145.88 $150.85 $144.45 $150.46 844 937
Jun 04, 2021 $147.43 $148.00 $144.02 $145.60 413 260
Jun 03, 2021 $141.82 $148.59 $140.39 $147.29 556 274
Jun 02, 2021 $143.86 $145.24 $142.16 $142.85 760 943
Jun 01, 2021 $142.23 $145.15 $141.11 $144.28 583 534
May 28, 2021 $140.95 $144.72 $139.85 $141.99 490 460
May 27, 2021 $139.59 $142.25 $136.85 $140.23 409 929
May 26, 2021 $140.74 $141.54 $138.28 $138.80 427 855
May 25, 2021 $139.35 $140.39 $138.05 $139.40 504 254
May 24, 2021 $141.34 $141.56 $138.14 $138.28 339 034
May 21, 2021 $140.63 $142.05 $138.98 $140.06 328 349
May 20, 2021 $135.25 $140.68 $132.46 $140.10 367 493
May 19, 2021 $133.24 $137.24 $133.02 $134.93 432 355
May 18, 2021 $135.39 $138.44 $134.23 $135.15 238 221
May 17, 2021 $135.21 $136.69 $134.06 $135.89 262 111
May 14, 2021 $133.68 $137.65 $131.58 $135.70 449 507
May 13, 2021 $134.29 $134.92 $127.72 $132.92 606 871
May 12, 2021 $131.27 $135.24 $131.07 $133.36 440 709
May 11, 2021 $126.45 $133.36 $125.08 $132.41 496 783
May 10, 2021 $131.28 $131.28 $127.22 $128.63 307 238
May 07, 2021 $133.44 $135.49 $130.76 $131.30 238 536
May 06, 2021 $132.00 $134.00 $128.71 $132.10 630 167
May 05, 2021 $131.64 $133.29 $129.14 $132.67 612 599
May 04, 2021 $134.64 $135.69 $130.46 $131.57 570 957
Click to get the best stock tips daily for free!

About Alnylam Pharmaceuticals

Alnylam Pharmaceuticals Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system (CNS)/ocular diseases. Its marketed products include ONPATTRO (patisiran), a lipid complex injection f... ALNY Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT